Krishnan E C, Krishnan L, Jewell W R
J Surg Oncol. 1981;16(1):93-101. doi: 10.1002/jso.2930160114.
Over the past five years 86 malignant tumors were assayed for cell surface IgG, elutable Ag-Ab complexes, and/or cell surface Fc receptors. Surface IgG was measured by indirect radioimmunoassay, using single-cell suspensions and tumor eluates. Fc receptors in tissue sections were identified by the closed chamber technique. The results confirm our previous finding that human tumors are coated in vivo with IgG and that there is a population of cells within solid tumors capable of binding Ag-Ab complexes. In addition, Ag-Ab complexes appear to attach to the cell surface membrane by the Fc zone of antibody. Ag-Ab binding was inhibited by antibody raised against the tumor. Indirect complement consumption assay indicated the presence of Ag-Ab complexes in tumor eluates. It appears that most cell surface immunoglobulin is complexed.
在过去五年中,对86例恶性肿瘤进行了细胞表面IgG、可洗脱的抗原-抗体复合物和/或细胞表面Fc受体的检测。使用单细胞悬液和肿瘤洗脱液,通过间接放射免疫测定法测量表面IgG。组织切片中的Fc受体通过封闭室技术进行鉴定。结果证实了我们之前的发现,即人类肿瘤在体内被IgG包被,实体瘤内存在一群能够结合抗原-抗体复合物的细胞。此外,抗原-抗体复合物似乎通过抗体的Fc区附着于细胞表面膜。针对肿瘤产生的抗体可抑制抗原-抗体结合。间接补体消耗试验表明肿瘤洗脱液中存在抗原-抗体复合物。似乎大多数细胞表面免疫球蛋白都形成了复合物。